M. Eefting

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination

G. J. Bakker, T. Langerak, M. N. Lauw, 2022, Thrombosis Research.

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction

A. Kruisselbrink, K. Szuhai, E. Jordanova, 2018, Front. Immunol..

Invasive fungal infections in patients treated with Bruton's tyrosine kinase inhibitors.

B. Rijnders, M. Joosse, M. Eefting, 2020, The Netherlands journal of medicine.

Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme

E. Vellenga, B. Biemond, A. A. van de Loosdrecht, 2011, British journal of haematology.

Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response

Marcelo A. Navarrete, J. Falkenburg, F. Claas, 2017, The Journal of clinical investigation.

Overwhelming primary Epstein–Barr virus infection requiring corticosteroid treatment

C. van Nieuwkoop, M. Eefting, M. Janssen, 2011, BMJ Case Reports.

COVID-19 vaccination in patients with immune thrombocytopenia

E. van Werkhoven, F. Leebeek, M. Kruip, 2021, Blood Advances.

Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme

E. Vellenga, B. Biemond, A. A. van de Loosdrecht, 2011, British journal of haematology.